Recently, TWEAK-Fn14 signaling has been reported to play an important role in the progression of lupus nephritis and anti-TWEAK blocking antibodies can preserve renal function and increase survival rate in experimental models of CKD (Gomez et al., 2016; Sanz et al., 2014). Here, TNFSF12 is linked to lupus nephritis.